The popularity of copyright’s blockbuster initially drove a period of growth for pharma, but recent changes present a murky picture for investors. Off-patent competitors are eroding profits, and persistent litigation https://lawsonjuaz480087.like-blogs.com/41032336/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment